Literature DB >> 19243859

Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures.

Cassandra D Salgado1, Patrick D Mauldin, Pamela J Fogle, John A Bosso.   

Abstract

BACKGROUND: In October 2004, our Clostridium difficile infection (CDI) rate increased (relative risk, 3.51; 95% confidence interval: 2.96-4.16) from a baseline rate of 1.35 per 1000 patient-days. We describe the outbreak, the relationship between antibiotic use and CDI, and the effect of enhanced infection control measures (EICM) on CDI.
METHODS: Rates were calculated as positive C difficile toxin A or B tests among patients with nosocomial diarrhea per 1000 patient-days (duplicates removed). Antibiotic use was calculated as defined daily dose per 1000 patient-days. EICM consisted of (1) placing patients with diarrhea into empiric Contact Precautions, (2) cleaning with a bleach product in areas with CDI patients, and (3) requiring soap and water hand hygiene when caring for CDI patients. CDI rates were analyzed by chi(2) for trend. Time series methodology was used to examine the association between CDI and antibiotic use.
RESULTS: During the outbreak (October 2004-May 2005), we observed 144 excess cases of CDI. The CDI rate decreased after EICM were implemented (P < .0001) and has been maintained for 36 months beyond the outbreak. Multivariate analysis revealed positive associations between CDI rates and cefazolin use (P = .008) and levofloxacin/gatifloxacin use (P = .015).
CONCLUSION: Despite an association between some antibiotic use and CDI rates, we achieved sustained control of an outbreak using EICM without formulary changes or new antibiotic control policies. This suggests that patient-to-patient spread may be a more important cause of increased CDI rates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243859     DOI: 10.1016/j.ajic.2008.11.010

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

1.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 2.  Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles.

Authors:  Anna K Barker; Caitlyn Ngam; Jackson S Musuuza; Valerie M Vaughn; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2017-03-27       Impact factor: 3.254

3.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 4.  Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention.

Authors:  Irene K Louh; William G Greendyke; Emilia A Hermann; Karina W Davidson; Louise Falzon; David K Vawdrey; Jonathan A Shaffer; David P Calfee; E Yoko Furuya; Henry H Ting
Journal:  Infect Control Hosp Epidemiol       Date:  2017-04       Impact factor: 3.254

5.  When is an outbreak an outbreak? Using literature and discharge data to define Clostridioides difficile incidence changes referred to as outbreaks.

Authors:  C C Cohen; G Azhar; L Muggy
Journal:  J Hosp Infect       Date:  2020-03-20       Impact factor: 3.926

6.  Clostridium difficile-associated disease: adherence with current guidelines at a tertiary medical center.

Authors:  Bryan F Curtin; Yousef Zarbalian; Mark H Flasar; Erik von Rosenvinge
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

7.  Assessing control bundles for Clostridium difficile: a review and mathematical model.

Authors:  Laith Yakob; Thomas V Riley; David L Paterson; John Marquess; Archie Ca Clements
Journal:  Emerg Microbes Infect       Date:  2014-06-18       Impact factor: 7.163

8.  Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review.

Authors:  Guillaume Gingras; Marie-Hélène Guertin; Jean-François Laprise; Mélanie Drolet; Marc Brisson
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

9.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.